Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are starting radiation treatment for a brain tumor
- People who are between 8 and 22 years old at the time of joining the trial
- People whose primary language is English or Spanish
- People (and one of their parents) who are willing to take part and give their agreement to participate, following the rules of the institution running the trial
- People who are willing to take part in the required parts of a computer-based memory training program called Cogmed
Who may not be able to join:
- People whose general intellectual ability, based on standardized testing, is estimated to be significantly below average (an IQ score below 70)
- People who have a history of a significant brain or nervous system condition before their brain tumor diagnosis, such as a stroke or a head injury that caused loss of consciousness
- People who have a major physical impairment — such as blindness, significant muscle weakness, poorly controlled seizures, or difficulty sitting or standing without help — that would prevent them from completing the cognitive (thinking and memory) tests or training in the study
- People who have a mental health condition that would prevent or take priority over taking part in the study, such as active psychosis or thoughts of suicide
- People who need to be put under full general anesthesia during their daily radiation treatment sessions (note: people who only need sedation during the planning stage of radiation, but not during the daily treatments themselves, may still be eligible — confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Andrew Heitzer, PhD, ABPP-CN, St. Jude Children's Research Hospital
Phone: 888-226-4343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Participation Rate; Adherence; Side Effects
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.